NOT-DA-18-039: Notice of NIDA's participation in PAR-18-930 "Development and Optimization of Tasks and Measures for Functional Domains of Behavior (R01 Clinical Trial Not Allowed)"

Notice of NIDA's participation in PAR-18-930 "Development and Optimization of Tasks and Measures for Functional Domains of Behavior (R01 Clinical Trial Not Allowed)"

Notice Number: NOT-DA-18-039

Key Dates
Release Date: September 25, 2018

Related Announcements
PAR-18-930

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The following changes have been made to reflect NIDA's participation in this FOA:

Part 1. Overview Information

Components of Participating Organizations

National Institute of Mental Health (NIMH)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute on Drug Abuse ( NIDA)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.242; 93.273, 93.279

Section VII. Agency Contacts

The following contacts have been added:

Scientific/Research Contact(s)

Tanya Ramey, M.D., Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-5944
Email: tanya.ramey@nih.gov

Financial/Grants Management Contact(s)

Pam Fleming
National Institute on Drug Abuse (NIDA)
Telephone: 301-480-1159
Email: pfleming@nida.nih.gov

Inquiries

Please direct all inquiries to:

Tanya Ramey, M.D., Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-5944
Email: tanya.ramey@nih.gov